🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our free webinar on Precision MRD Assessments is almost here! Get ready to deep dive into cutting-edge approaches for clonal rearrangement detection and ultra-sensitive #MRD workflows. Register now: hubs.li/Q03k_9Px0 #clonality #precisiondiagnostics #MolecularPathology

Optimized for high-throughput, multiple-target NGS pipelines for LymphoTrack® Flex Assays identify gene rearrangements and somatic hypermutation status in < 50 hours. Click here to learn more hubs.li/Q03hRbKr0 #clonality #precisiondiagnostics #NGS #leukemia #lymphoma

Every cancer journey is unique—but one thing is clear: measurable residual disease monitoring improves patient outcomes. Visit hubs.li/Q03lPw_p0 to learn about our MRD services. #NCRM #Leukemia #Lymphoma #AML #ALL #Myeloma #MRD

Join us at #ASCO25 and #EHA2025 to learn how our Streamlined CDx and ultra-sensitive MRD services at our globally standardized lab network can be used as surrogate endpoints. hubs.li/Q03lWRLL0 #LabPMM #MRD #MFC #CDx #PrecisionMedicine

Innovative research has paved the way for ultra-sensitive #MRD assessments — bringing new hope to people worldwide as they move beyond cancer and into brighter futures. Click here to learn how to advance your oncology research this #CancerResearchMonth. hubs.li/Q03n8v0y0

Meet with us at #ASCO25 to inquire about our MFC screening panel and measurable residual disease testing services for acute myeloid leukemia and chronic lymphocytic leukemia. hubs.li/Q03nzSfp0 #ASCO2025 #LabPMM #Invivoscribe #AML #CLL #MRD

Congratulations to our Spring Biotech 2025 Softball team for finishing the season in first place! We appreciate your hard work on and off the field. #Biotech #Softball #BiotechSoftball #Teamwork

Our team joined the Japanese Society of Hematology International Symposium in Saga, Japan this past weekend. It was great to see the new developments in diagnosis, monitoring, and treatment for patients with hematologic malignancies. hubs.li/Q03nS8Bk0 #LabPMM

We are counting down the days to #ASCO25! Stop by booth #31123 to learn how our innovative products and services are advancing precision diagnostics and personalized medicine in oncology. hubs.li/Q03n8l0N0 #LabPMM #MRD #MFC #CDx #PrecisionMedicine #ASCO2025

Using MRD as a surrogate endpoint enables faster decision-making during clinical trials. Connect with us at #ASCO25 to explore even more benefits! hubs.li/Q03n086v0 #MRD #clinicaltrials #ASCO2025 #LabPMM #Invivoscribe

FLT3 ITD MRD Software v3.0.0 is here with powerful new features! hubs.li/Q03pC7360 #AML #FLT3ITD #MRD #Invivoscribe

#ASCO25 is officially underway and we’re here at booth #31123! Stop by our booth to chat with the Invivoscribe team and learn how we're driving innovation in precision diagnostics and oncology. See you soon! #ASCO2025 #LabPMM #Invivoscribe #AML #CLL #MRD #NGS

What a comeback! Our Invivoscribe softball team pulled off an incredible rally in Game 1 the other night—coming back from a 15–1 deficit to take the win and advance to the championship game! 🥎 We’re proud of this team! #TeamInvivoscribe #SoftballSeason #BiotechAndBaseball

Using MRD as a surrogate endpoint enables faster decision-making during clinical trials. Schedule a meeting with us at #EHA2025 to explore how MRD can accelerate your drug development. hubs.li/Q03qNRgm0 #MRD #clinicaltrials #EHA25 #LabPMM #Invivoscribe

Invivoscribe’s international network of clinical labs, LabPMM, provides globally standardized tests that meet the highest quality and service standards. hubs.li/Q03rKPJm0 #EHA2025 #MRD #NGS #CDx

Reporting live from Milan, we’re here at booth #E074! Stop by our booth to chat with our team on how we improve lives with precision diagnostics worldwide. See you soon! #MRD #clinicaltrials #EHA25 #EHA2025

Stop by Booth #E07A at #EHA2025 to learn about our globally standardized services. #MRD #LabPMM #AML #Clonality #CDx #FLT3 #NPM1

Invivoscribe’s LabPMM has received NYS approval for its NPM1 MRD Assay—just 2 months after FLT3 ITD MRD approval. These standardized, sensitive assays enable accurate #MRD monitoring in #AML, supporting clinical and therapeutic decision-making. Read more: hubs.li/Q03sDSH70